ES8605771A1 - Procedimiento para preparar un polipeptido - Google Patents

Procedimiento para preparar un polipeptido

Info

Publication number
ES8605771A1
ES8605771A1 ES542310A ES542310A ES8605771A1 ES 8605771 A1 ES8605771 A1 ES 8605771A1 ES 542310 A ES542310 A ES 542310A ES 542310 A ES542310 A ES 542310A ES 8605771 A1 ES8605771 A1 ES 8605771A1
Authority
ES
Spain
Prior art keywords
image
denotes
agents containing
peptides
isolation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542310A
Other languages
English (en)
Other versions
ES542310A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8605771A1 publication Critical patent/ES8605771A1/es
Publication of ES542310A0 publication Critical patent/ES542310A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

METODO DE PREPARACION DE POLIPEPTIDOS Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES DE FORMULA (I), EN LA QUE M Y N VALEN 0-50 Y 0-100, RESPECTIVAMENTE; R ES EL HIDROGENO FENOLICO O UN GRUPO ESTER FENOLICO; X Y Z SON RADICALES DE A-AMINOACIDOS; E Y REPRESENTA UNO DE VARIOS AMINOACIDOS. CONSISTE EN SOMETER HIRUDINA A UNA DOBLE DEGRADACION DE EDMAN; SEGUIDA DE LA REACCION DEL PEPTIDO FORMADO CON UN ESTER ACTIVO DE UN AMINOACIDO O DE UN PEPTIDO DE FORMULA U-(X)M-Y-OH, EN LA QUE U ES UN GRUPO PROTECTOR DE URETANO Y M, X E Y TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I); SEPARACION DEL GRUPO FENILTIOCARBAMOILO SITUADO EN LA FUNCION E-AMINO DE LYS MEDIANTE HIDRAZINA; Y SEPARACION DEL GRUPO PROTECTOR DE URETANO CON UNA BASE O UN ACIDO. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA LA PROFILAXIS Y TERAPIA DE PROCESOS TROMBO-EMBOLICOS.
ES542310A 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido Granted ES542310A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414593 1984-04-18
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
ES8605771A1 true ES8605771A1 (es) 1985-12-16
ES542310A0 ES542310A0 (es) 1985-12-16

Family

ID=25820510

Family Applications (3)

Application Number Title Priority Date Filing Date
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542310A Granted ES542310A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542309A Expired ES8605770A1 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES542309A Expired ES8605770A1 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado

Country Status (18)

Country Link
US (1) US4668662A (es)
EP (1) EP0158986B1 (es)
JP (1) JP2552263B2 (es)
KR (1) KR930000054B1 (es)
AR (1) AR242800A1 (es)
AU (1) AU580295B2 (es)
CA (1) CA1271298A (es)
DE (2) DE3438296A1 (es)
DK (1) DK171824B1 (es)
ES (3) ES542311A0 (es)
FI (1) FI851521L (es)
GR (1) GR850942B (es)
HU (1) HU198085B (es)
IE (1) IE60581B1 (es)
IL (1) IL74948A (es)
NO (1) NO851535L (es)
PT (1) PT80301B (es)
ZA (1) ZA852854B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
ES2055149T3 (es) * 1985-04-11 1994-08-16 Hoechst Ag Derivado de hirudina.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
WO1989011290A1 (en) * 1988-05-27 1989-11-30 Magainin Sciences, Inc. Amphiphilic peptides and use thereof
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
JPH07504152A (ja) * 1990-02-08 1995-05-11 マゲイニン　ファーマスーティカルズ，　インコーポレーテッド 生物活性ペプチドおよび標的細胞、ウイルス、あるいはウイルス感染細胞の成長を抑制する方法
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
WO1991017760A1 (en) * 1990-05-14 1991-11-28 Magainin Sciences Inc. Composition of and treatment with biologically active peptides having d-amino acid residues
JPH05507718A (ja) * 1990-06-27 1993-11-04 マゲイニン　サイエンセズ　インコーポレーテッド 生物活性ペプチドおよびｄｎａギラーゼを阻害する抗生物質よりなる組成物と治療法
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
AU648096B2 (en) * 1990-07-24 1994-04-14 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
AU2901692A (en) * 1991-10-16 1993-05-21 Children's Hospital Of Philadelphia, The Composition and treatment with biologically active peptides and antibiotic
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
KR100330465B1 (ko) * 1993-06-11 2002-11-23 메렐 파마슈티칼스 인크. 삼관능성항트롬빈및항혈소판펩티드
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) * 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
EP0787569B1 (en) 1996-01-31 2002-10-02 Sumitomo Bakelite Company Limited Method of producing epoxy resin-encapsulated semiconductor device
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
CN102215953A (zh) * 2008-11-19 2011-10-12 安万托特性材料股份有限公司 基于苯氧基烷基和烷氧基-或苯氧基-苯基烷基配体的新色谱介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
EP0158564B1 (fr) * 1984-03-27 1992-07-15 Transgene S.A. Vecteurs d'expression de l'hirudine, cellules transformées et procédé de préparation de l'hirudine
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
DE3587576D1 (de) 1993-10-21
ES542309A0 (es) 1985-12-16
ES8605772A1 (es) 1985-12-16
PT80301A (de) 1985-05-01
JPS60233098A (ja) 1985-11-19
ES8605770A1 (es) 1985-12-16
HU198085B (en) 1989-07-28
DK171824B1 (da) 1997-06-23
FI851521L (fi) 1985-10-19
AU580295B2 (en) 1989-01-12
NO851535L (no) 1985-10-21
AU4136485A (en) 1985-10-24
KR930000054B1 (ko) 1993-01-06
IL74948A0 (en) 1985-08-30
IE60581B1 (en) 1994-07-27
ES542310A0 (es) 1985-12-16
FI851521A0 (fi) 1985-04-16
DK173985D0 (da) 1985-04-17
HUT37806A (en) 1986-02-28
IL74948A (en) 1989-09-10
EP0158986B1 (de) 1993-09-15
KR850007801A (ko) 1985-12-09
US4668662A (en) 1987-05-26
EP0158986A3 (en) 1988-09-21
DK173985A (da) 1985-10-19
PT80301B (de) 1987-02-10
CA1271298A (en) 1990-07-03
AR242800A1 (es) 1993-05-31
JP2552263B2 (ja) 1996-11-06
ES542311A0 (es) 1985-12-16
ZA852854B (en) 1985-11-27
EP0158986A2 (de) 1985-10-23
GR850942B (es) 1985-11-25
DE3438296A1 (de) 1985-11-07
IE850983L (en) 1985-10-18

Similar Documents

Publication Publication Date Title
ES8605771A1 (es) Procedimiento para preparar un polipeptido
ES2000216A6 (es) Procedimiento para preparar un polipeptido purificado que tiene propiedades inhibidoras de la coagulacion de la sangre.
EP0151246A3 (en) Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations
DE3166150D1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation
AU5553790A (en) Cysteine added variants of polypeptides and chemical modifications thereof
NZ238208A (en) Polypeptides with amino acid sequence substantially that of human fibronectin fibrin binding domain, their preparation and compositions and imaging agents containing them
ZA858328B (en) Peptides selected from amino acid residues 11 to 23 of vip
IL134982A0 (en) Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith
BG43355A3 (en) Method for preparing of physiologically active polypeptide
AU6286986A (en) Peptide analogues of mammalian insulin-like growth factor-1
IL72630A (en) Growth hormone-releasing peptides,their preparation and pharmaceutical preparations therefrom
ES489522A0 (es) Un procedimiento para la preparacion de un polipeptido
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
EP0249477A3 (en) Functional recombinant analog polypeptides devoid of hydrophobic amino acids
EP0249412A3 (en) C-terminal alpha-amidating enzyme and process for production and use thereof
AU2399784A (en) Cyclic peptides having somatostatin activity
IL83990A0 (en) Cell membrane proteins,compositions containing them and procedure for their preparation
CA2004764A1 (en) Ancrod proteins, their preparation and use
WO1990012807A3 (en) Purified, highly specific antibodies against gene products including retinoblastoma and method
GB2195641A (en) Polypeptide with interleukin-2 activity
NO873751L (no) Lymfocytt-aktiverende polypeptider.
DK652889A (da) Fremgangsmaade til fremstilling af et protein eller polypeptid

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506